CNS & Neurological Disorders-Drug Targets

Papers
(The H4-Index of CNS & Neurological Disorders-Drug Targets is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Meet the Editorial Board Member79
Meet the Regional Editor68
Na+/HCO3− Co-transporters Inhibitor S0859 Attenuates Global Cerebral Ischemia-reperfusion Injury of the CA1 Neurons in the Gerbil’s Hippocampus53
Decoding the Inter-Relationship between Sleep Disorders and Alzheimer’s Disease Pathogenesis44
Hypomyelination with Atrophy of Basal Ganglia and Cerebellum (HABC) Due to UFM1 Mutation in Roma Patients - Severe Early Encephalopathy with Stridor and Severe Hearing and Visual Impairment. A Single 44
Neurobiology of Amphetamine use in Stroke Recovery Combined with Rehabilitative Training and Brain Stimulation43
Effects of α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator on BDNF, NKCC1 and KCC2 Expression in the Hippocampus following Lipopolysaccharide-Induced Allodynia and Hyperalgesia in a 38
Emerging Nanotechnology for the Treatment of Alzheimer’s Disease38
Restless Leg Syndrome in Patients with Liver Cirrhosis! Its Frequency, Severity, and Correlation34
Recent Trends in Physical Therapy Interventions and Neuromodulation Techniques to Improve Neurorehabilitation30
Targeting JNK3: An In-silico Approach to Uncover Potential Therapeutics for Alzheimer’s Disease28
The Potential Effect of Blueberry on Cognitive Health and Mood State based on Human Intervention Studies: Systematic Review and Mini Meta-Analysis25
Memory Reflections of the Microbiota-Gut and Oligodendrocyte Axis25
The Natural Neuroprotective Compounds Used in the 6-Hydroxydopamine- Induced Parkinson’s Disease in Zebrafish: The Current Applications and Perspectives25
CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment23
Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review23
Monoamine Oxidase: A Potential Link in Papez Circuit to Generalized Anxiety Disorders22
GFAP and UCHL1 in Non-traumatic SAH: The Story thus Far. A Systematic Review of the Literature22
Intracerebral Hemorrhage and Diabetes Mellitus: Blood-Brain Barrier Disruption, Pathophysiology and Cognitive Impairments22
Insights into the Diagnosis, Treatment, and Management of Prion Diseases22
Molecular and Biochemical Pathways Encompassing Diabetes Mellitus and Dementia21
Cholinesterase Inhibitory and In Silico Toxicity Assessment of Thirty-Four Isoquinoline Alkaloids - Berberine as the Lead Compound21
The Emerging Role of Marine Natural Products for the Treatment of Parkinson’s Disease21
0.4804630279541